Rock Springs Capital Management LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001595725

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q4 2025 · 97 positions · Total reported value $1.92B · Top-10 concentration 40.4% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 39.8% · 9 new · 28 cut · 8 exited

Active Share (vs S&P 500): 96.8% · vs QQQ: 99.2% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -7.5% · vs SPY -9.6% · Prev Value $2.05B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -2.4% · vs SPY -4.5% · Latest Value $1.85B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q4 2025 13F filing, Rock Springs Capital Management LP disclosed 97 equity positions with a combined reported value of $1.92B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 40.4% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q4 2025 were LLY ($113.27M), RVMD ($106.35M), ARGX ($86.83M). By sector, the heaviest allocations are Health Care 85.0%, Consumer Discretionary 1.3%. Versus the prior quarter, allocation shifted toward Health Care (+1.7pp) and away from Other (-0.9pp), Consumer Discretionary (-1.2pp).

Versus the prior quarter, Rock Springs Capital Management LP opened 9 new positions, trimmed 28 and fully exited 8, a turnover rate of 39.8% of positions. The portfolio's overlap with the prior quarter was 72% of names.

The largest new positions opened in Q4 2025 were UNH ($13.47M), IMNM ($7.47M), RAPT ($7.24M).

Of the 8 positions fully exited versus the prior quarter, the largest were MRUS ($56.21M), AKRO ($29.75M), MREO ($9.42M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2025)

  • UNH UNITEDHEALTH GROUP INC · $13.47M
  • IMNM IMMUNOME INC · $7.47M
  • RAPT RAPT THERAPEUTICS INC · $7.24M
  • SGRY SURGERY PARTNERS INC · $4.79M
  • PTCT PTC THERAPEUTICS INC · $4.70M
  • TERN TERNS PHARMACEUTICALS INC · $4.38M
  • RCUS ARCUS BIOSCIENCES INC · $4.29M
  • TBPH THERAVANCE BIOPHARMA INC · $3.91M

Fully Exited (vs previous quarter)

  • MRUS MERUS N V · prev qtr: $56.21M
  • AKRO AKERO THERAPEUTICS INC · prev qtr: $29.75M
  • MREO MEREO BIOPHARMA GROUP PLC · prev qtr: $9.42M
  • WST WEST PHARMACEUTICAL SVSC INC · prev qtr: $2.56M
  • KRRO KORRO BIO INC · prev qtr: $1.71M
  • CATX PERSPECTIVE THERAPEUTICS INC · prev qtr: $1.52M
  • APLT APPLIED THERAPEUTICS INC · prev qtr: $1.26M
  • IMVT IMMUNOVANT INC · prev qtr: $1.18M

Insider Transactions (Form 4)

Latest Rock Springs Capital Management LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Rock Springs Capital Management LP is an SEC-registered 13F filer based in Baltimore, MD, United States. As of Q2 2026 it reported 104 US equity positions with a combined value of $2.05B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: BALTIMORE, MD, United States
  • SEC registration: 801-78511 (status: Approved), registered 2013-09-27
  • Regulatory AUM (Form ADV): $2.43B as of 2026-03-24
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 2 private funds, of which 2 hedge funds

Portfolio Structure

  • 104 positions · $2.05B reported value (Q2 2026)
  • Top 10 holdings = 44.0% of reported value
  • Largest position: RVMD (REVOLUTION MEDICINES INC) at 10.1%
  • Average position size: $19.70M

Sector Tilt

  • Health Care 96.8%
  • Industrials 1.1%
  • Consumer Discretionary 1.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 16 new, 35 added, 31 reduced, 12 exited
  • 22 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 85.0%
Technology 1.0%
Other 11.4%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 105.40K $113.27M 5.90%
5.90%
Hold
2 1.34M $106.35M 5.54%
5.54%
Hold
3 103.25K $86.83M 4.52%
4.52%
Reduce
4 2.21M $84.46M 4.40%
4.40%
Add
5 139.62K $81.31M 4.23%
4.23%
Add
6 695.01K $74.39M 3.87%
3.87%
Reduce
7 601.80K $61.12M 3.18%
3.18%
Add
8 762.29K $60.21M 3.13%
3.13%
Hold
9 319.25K $55.56M 2.89%
2.89%
Reduce
10 748.24K $52.04M 2.71%
2.71%
Reduce
11 82.00K $46.44M 2.42%
2.42%
Hold
12 204.88K $45.26M 2.36%
2.36%
Reduce
13 203.50K $43.39M 2.26%
2.26%
Reduce
14 235.00K $41.70M 2.17%
2.17%
Hold
15 496.87K $38.66M 2.01%
2.01%
Add
16 399.05K $38.05M 1.98%
1.98%
Add
17 120.50K $37.46M 1.95%
1.95%
Hold
18 787.79K $35.31M 1.84%
1.84%
Reduce
19 733.48K $32.31M 1.68%
1.68%
Reduce
20 849.03K $30.16M 1.57%
1.57%
Reduce
21 1.27M $29.15M 1.52%
1.52%
Add
22 568.58K $28.79M 1.50%
1.50%
Reduce
23 71.25K $28.33M 1.48%
1.48%
Reduce
24 1.93M $27.48M 1.43%
1.43%
Reduce
25 222.00K $27.07M 1.41%
1.41%
Add
26 125.00K $24.84M 1.29%
1.29%
Hold
27 347.30K $23.05M 1.20%
1.20%
Add
28 799.16K $21.75M 1.13%
1.13%
Reduce
29 260.34K $21.32M 1.11%
1.11%
Reduce
30 3.93M $21.09M 1.10%
1.10%
Reduce
31 569.10K $18.93M 0.99%
0.99%
Add
32 692.54K $18.81M 0.98%
0.98%
Reduce
33 687.50K $18.55M 0.97%
0.97%
Reduce
34 502.08K $18.23M 0.95%
0.95%
Reduce
35 912.96K $17.86M 0.93%
0.93%
Add
36 125.50K $17.80M 0.93%
0.93%
Add
37 623.40K $17.30M 0.90%
0.90%
Hold
38 427.60K $15.52M 0.81%
0.81%
Add
39 876.60K $14.83M 0.77%
0.77%
Add
40 811.55K $14.32M 0.74%
0.74%
Add
41 61.50K $14.08M 0.73%
0.73%
Hold
42 40.80K $13.47M 0.70%
0.70%
New
43 2.30M $13.41M 0.70%
0.70%
Add
44 4.45M $13.41M 0.70%
0.70%
Reduce
45 710.00K $12.42M 0.65%
0.65%
Hold
46 798.40K $12.30M 0.64%
0.64%
Add
47 131.00K $12.08M 0.63%
0.63%
Add
48 740.00K $11.68M 0.61%
0.61%
Reduce
49 247.05K $11.44M 0.60%
0.60%
Add
50 169.86K $11.07M 0.58%
0.58%
Reduce

FAQ

What did Rock Springs Capital Management LP buy in 2025-Q4?

In its 2025-Q4 13F filing, Rock Springs Capital Management LP reported 97 equity positions worth $1.92B in aggregate; its largest disclosed positions were LLY ($113.27M), RVMD ($106.35M), ARGX ($86.83M).

How large is Rock Springs Capital Management LP's portfolio?

Rock Springs Capital Management LP reported $1.92B of long equity holdings across 97 positions as of 2025-Q4. Top-10 holdings account for 40.4% of reported value.

What is Rock Springs Capital Management LP's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/rock-springs-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →